ArticleJournal of veterinary internal medicine2026
Prolonged survival of 3 dogs with Prototheca bovis infection treated with posaconazole.
Article in Journal of veterinary internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary enteric or disseminated infections with Prototheca bovis in dogs typically are associated with short survival times despite treatment. We describe the extended clinical course of 3 dogs diagnosed with enteric P. bovis infection treated with antifungal therapy incorporating posaconazole. One dog was alive 45 months after starting treatment, exhibiting only mild, intermittent diarrhea and no detectable algae on rectal cytology. This dog also received SC amphotericin B (AMB) infusions during the first month after diagnosis. The second dog, managed exclusively with posaconazole, was alive after 39 months with moderate mixed-bowel diarrhea and ongoing P. bovis shedding but without clinical signs of dissemination. The third dog survived 21 months before death because of central nervous system dissemination; additional treatments included itraconazole, AMB, terbinafine, and immunotherapy using an autologous vaccine. Posaconazole was well tolerated in all dogs and can be considered a therapeutic option for dogs with enteric protothecosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.